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The problems of cancer, regardless of its clinical localization, 
are principally directed to the impossibility to identify and to preci-
sionize the role of the immune system in the course of development 
of cancer process. The only fact confirmed at present is that by using 
future selective (at definite level of performance of the immune re­
sponse against timour antigens) immunomodulators we could most 
probably have a positive specific therapeutic effect. Naturally, when 
it is a question of urgent surgical interventions, it is most essential to 
evaluate (again based on a dynamic analysis of the immune status 
before and after operation) the actual criteria and indications for sur­
gical treatment. Therefore, being unable to apply those future immu­
nomodulators at the moment, we suggest our model of immunologic 
monitoring for patients with сою-rectal cancer (CRC) in order to di­
agnose the stages of cancer process, to predict postoperative state, 
to find out the necessity (or not?) of operative treatment, as well as 
to control the applied immunotherapy, corticosteroids, etc. 
Our study covers 54 patients with verified CRC from the Clinic 
of Proctology. The examined contingent is shown on table 1. 
Table 1. Contingent of examined patients 
Contingent Total number Age Male Female 
Patients 54 29-74 39 (72%) 15(28%) 
The following methods are applied in dynamic immunologic 
monitoring: 1) reaction blast-transformation - RBT; 2) Т-RFC and B-
RFC; 3) Т-helper and Т-suppressor cells, index Th/Ts; 4) monocyte 
rosettes (receptors Fc and Сз); 5) eosinophile activity (in % ) ; 6) mac­
rophage activity (NBT-test), spectrophotometric ED; 7) enzymatic 
activity (SDH, a -GPDH, LDH); 8) Сз-complement component; 9) cir­
culating immune complexes, CIC; 10) lysozyme (in serum); 11) clini-
co-laboratory data (in regard to CRC). 
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The periods of dynamic investigation of CRC patients are as fol­
lows: 1) date of admission, before operation (if indicated?); 2) in­
traoperative investigation; 3) early postoperative period (48 h); 4) 
postoperative examination (up to 10 days); 5) late postoperative 
screening (1-2...? months). 
Fig. 1 shows the dynamics of all tests applied in our model of 
immunologic monitoring parallelly and simultaneously for any indi­
vidual patient. It is obvious that there are certain changes in the ac­
tivity of the cellular, humoral immunity, specific tests corresponding 
to various periods before, during and after operation. 
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Fig. 1. Graphical presentation of tests in dynamics 
D.A. - date of admittance; I.O.I. - intraoperative investigation; E.P.P. 
- early postoperative period; P.O.E. - postoperative examination; 
L P S . - late postoperative screening; B.L - background level 
The background data allow to determine also high or low im­
mune response. As a result, patients with higher type have better pos­
toperative fate, less recidivs, quicker restoration; patients with lower 
type - often lethality (11 from 54 patients with CRC die; 9*from 11 with 
lower type). Based on our complex analysis we could suggest cer­
tain immunologic criteria for CRC patients indicated to surgical treat­
ment. 
